Drugs / [18F]CETO
[18F]CETO
also known as
para-chloro-2-\[18F\]fluoroethyl etomidate · CETO · Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO)
Diagnostic / imaging agent targets CYP11B1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05472493 | Jan 2023 → Jun 2026 overdue | primary aldosteronism | University of Calgary | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04529018 | Aug → Nov 2020 | primary aldosteronism | University of Cambridge | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06616142 Comparator | Nov 2024 → Oct 2026 expected | primary aldosteronism | University Medical Center Groningen | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]CETO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06616142 ↗ |
| Known as | CETO | “This study is to evaluate the accuracy of a novel radiopharmaceutical tracer, para-chloro-2-\[18F\]fluoroethyl etomidate (CETO), used with positron emission tomography (PET)...” NCT05472493 ↗ |
| Known as | Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO) | “Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO)” NCT06616142 ↗ |
| Known as | para-chloro-2-\[18F\]fluoroethyl etomidate | “This study is to evaluate the accuracy of a novel radiopharmaceutical tracer, para-chloro-2-\[18F\]fluoroethyl etomidate (CETO), used with positron emission tomography (PET)...” NCT05472493 ↗1“para-chloro-2-[18F]fluoroethyletomidate ([18F]CETO)” PMID 39884776 ↗ Mar 2025 |
| Modality | Diagnostic / imaging agent | “[18F]CETO is a safe radiopharmaceutical for PET imaging of the adrenal glands” PMID 39884776 ↗ Mar 2025 |
| Route | Intravenous | “will be administered as a single dose intravenously” NCT05472493 ↗ |
| Target | CYP11B1 | “high specificity for the steroidogenic enzymes CYP11B1” NCT06616142 ↗ |